695
Views
128
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Oxidative stress biomarkers in sporadic ALS

, , , , , , , , , , , , , , & show all
Pages 177-183 | Received 09 Aug 2007, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Hiroshi Mitsumoto, Diana C. Garofalo, Madison Gilmore, Leslie Andrews, Regina M. Santella, Howard Andrews, Martin McElhiney, Jennifer Murphy, Jeri W. Nieves, Judith Rabkin, Jonathan Hupf, D. Kevin Horton, Paul Mehta & Pam Factor-Litvak. (2022) Case-control study in ALS using the National ALS Registry: lead and agricultural chemicals are potential risk factors. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 190-202.
Read now
Hiroshi Mitsumoto, Diana C. Garofalo, Regina M. Santella, Eric J. Sorenson, Björn Oskarsson, J americo M. Fernandes$suffix/text()$suffix/text(), Howard Andrews, Jonathan Hupf, Madison Gilmore, Daragh Heitzman, Richard S. Bedlack, Jonathan S. Katz, Richard J. Barohn, Edward J. Kasarskis, Catherine lomen-Hoerth, Tahseen Mozaffar, Sharon P. Nations, Andrea J. Swenson & Pam Factor-Litvak. (2020) Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 263-272.
Read now
Koji Takei, Kikumi Tsuda, Fumihiro Takahashi, Manabu Hirai & Joseph Palumbo. (2017) An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 88-97.
Read now
Koji Takei, Kazutoshi Watanabe, Satoshi Yuki, Makoto Akimoto, Takeshi Sakata & Joseph Palumbo. (2017) Edaravone and its clinical development for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 5-10.
Read now
H. Blasco, P. Vourc’h, P. F. Pradat, P. H. Gordon, C. R. Andres & P. Corcia. (2016) Further development of biomarkers in amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 16:8, pages 853-868.
Read now
Martin R. Turner, Robert Bowser, Lucie Bruijn, Luc Dupuis, Albert Ludolph, Michael McGrath, Giovanni Manfredi, Nicholas Maragakis, Robert G. Miller, Seth L. Pullman, Seward B. Rutkove, Pamela J. Shaw, Jeremy Shefner & Kenneth H. Fischbeck. (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup1, pages 19-32.
Read now
Pavel Rossner$suffix/text()$suffix/text() & Radim J. Sram. (2012) Immunochemical detection of oxidatively damaged DNA. Free Radical Research 46:4, pages 492-522.
Read now
Ali Aamer Habib & Hiroshi Mitsumoto. (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opinion on Emerging Drugs 16:3, pages 537-558.
Read now
Stefanie Grimm, Annika Hoehn, Kelvin J. Davies & Tilman Grune. (2011) Protein oxidative modifications in the ageing brain: Consequence for the onset of neurodegenerative disease. Free Radical Research 45:1, pages 73-88.
Read now
Daniel J. Amante, Jinho Kim, Samantha T. Carreiro, Andrew C. Cooper, Steven W. Jones, Ting Li, Jennifer P. Moody, Christina K. Edgerly, Olivia L. Bordiuk, Kerry Cormier, Karen Smith, Robert J. Ferrante & James Rusche. (2010) Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice. Amyotrophic Lateral Sclerosis 11:6, pages 520-530.
Read now

Articles from other publishers (118)

Rupesh Kumar, Md. Zubbair Malik, Thangavel Alphonse Thanaraj, Sali Abubaker Bagabir, Shafiul Haque, Murtaza Tambuwala & Shazia Haider. (2023) A computational biology approach to identify potential protein biomarkers and drug targets for sporadic amyotrophic lateral sclerosis. Cellular Signalling 112, pages 110915.
Crossref
Mary-Louise Rogers, David W Schultz, Vassilios Karnaros & Stephanie R Shepheard. (2023) Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations. Brain Communications 5:6.
Crossref
Akiko Yamamuro-Tanabe, Yasuhiro Kosuge, Yuki Ishimaru & Yasuhiro Yoshioka. (2023) Schwann cell derived-peroxiredoxin protects motor neurons against hydrogen peroxide-induced cell death in mouse motor neuron cell line NSC-34. Journal of Pharmacological Sciences 153:2, pages 73-83.
Crossref
John Paul Llido, Sri Jayanti, Claudio Tiribelli & Silvia Gazzin. (2023) Bilirubin and Redox Stress in Age-Related Brain Diseases. Antioxidants 12:8, pages 1525.
Crossref
Rupesh Kumar, Zubbair Malik, Manisha Singh, R. Rachana, Shalini Mani, Kalaiarasan Ponnusamy & Shazia Haider. (2023) Amyotrophic Lateral Sclerosis Risk Genes and Suppressor. Current Gene Therapy 23:2, pages 148-162.
Crossref
Richard J. Mead, Ning Shan, H. Joseph Reiser, Fiona Marshall & Pamela J. Shaw. (2022) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nature Reviews Drug Discovery 22:3, pages 185-212.
Crossref
A. N. Khabibrakhmanov, M. A. Mukhamedyarov & E. I. Bogdanov. (2023) Biomarkers for Amyotrophic Lateral Sclerosis. Neuroscience and Behavioral Physiology.
Crossref
Edward O. Olufunmilayo, Michelle B. Gerke-Duncan & R. M. Damian Holsinger. (2023) Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants 12:2, pages 517.
Crossref
Lan Gao, Peter Giannousis, Martin Thoolen, Diksha Kaushik, Joey Latham, Aaron Tansy, Jiyuan Ma, Mayzie Johnston, Mandar Dali, Lee Golden, Matthew Klein, Ronald Kong & Jeffrey Trimmer. (2022) First‐in‐Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15‐Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis. Clinical Pharmacology in Drug Development 12:2, pages 141-151.
Crossref
Shotaro Haji, Koji Fujita, Ryosuke Oki, Yusuke Osaki, Ryosuke Miyamoto, Hiroyuki Morino, Seiichi Nagano, Naoki Atsuta, Yuki Kanazawa, Yuki Matsumoto, Atsuko Arisawa, Hisashi Kawai, Yasutaka Sato, Satoshi Sakaguchi, Kenta Yagi, Tatsuto Hamatani, Tatsuo Kagimura, Hiroaki Yanagawa, Hideki Mochizuki, Manabu Doyu, Gen Sobue, Masafumi Harada & Yuishin Izumi. (2023) An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study. JMIR Research Protocols 12, pages e42032.
Crossref
Dobrina Tsvetkova, Stefka Ivanova & Danka Obreshkova. (2023)  Neurodegenerative Multioethiology Lou Gehrig’s Disease – Genetic Mutations, Pharmacological Mechanisms and Applications of Rilusole. International Journal of Pharmaceutical Research and Allied Sciences 12:3, pages 61-70.
Crossref
Sarah Hassan, Mario Eid, Ahmad Hassan & Samer El Hayek. 2023. Trace Elements in Brain Health and Diseases. Trace Elements in Brain Health and Diseases 155 168 .
Ira Agrawal, Yong Shan Lim, Shi-Yan Ng & Shuo-Chien Ling. (2022) Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. Translational Neurodegeneration 11:1.
Crossref
Laura Moreno-Martinez, Llipsy Santiago, Miriam de la Torre, Ana Cristina Calvo, Julián Pardo & Rosario Osta. (2022) Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan. International Journal of Molecular Sciences 23:21, pages 13554.
Crossref
Teresa Cunha‐Oliveira, Daniela Franco Silva, Luis Segura, Inês Baldeiras, Ricardo Marques, Tatiana Rosenstock, Paulo J. Oliveira & Filomena S. G. Silva. (2022) Redox profiles of amyotrophic lateral sclerosis lymphoblasts with or without known SOD1 mutations. European Journal of Clinical Investigation 52:9.
Crossref
Isabel Lastres-Becker, Eva de Lago, Ana Martínez & Javier Fernández-Ruiz. (2022) New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Biomolecules 12:9, pages 1200.
Crossref
Rupesh Kumar & Shazia Haider. (2022) Protein network analysis to prioritize key genes in amyotrophic lateral sclerosis. IBRO Neuroscience Reports 12, pages 25-44.
Crossref
Mónica Povedano, Andrés Paipa, Miquel Barceló, Michael K. Woodward, Sandra Ortega, Raúl Domínguez, Maria Esperança Aragonés, Raquel Horrillo, Montserrat Costa & Antonio Páez. (2021) Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study. Neurological Sciences 43:5, pages 3211-3221.
Crossref
Metka Ravnik-Glavač, Katja Goričar, David Vogrinc, Blaž Koritnik, Jakob Gašper Lavrenčič, Damjan Glavač & Vita Dolžan. (2022) Genetic Variability of Inflammation and Oxidative Stress Genes Affects Onset, Progression of the Disease and Survival of Patients with Amyotrophic Lateral Sclerosis. Genes 13:5, pages 757.
Crossref
Sudhanshu Sharma, Dia Advani, Ankita Das, Nishtha Malhotra, Akanksha Khosla, Vanshika Arora, Ankita Jha, Megha Yadav, Rashmi K Ambasta & Pravir Kumar. (2022) Pharmacological intervention in oxidative stress as a therapeutic target in neurological disorders. Journal of Pharmacy and Pharmacology 74:4, pages 461-484.
Crossref
Liaisan Arslanbaeva & Marco Bisaglia. (2022) Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment. Molecules 27:5, pages 1471.
Crossref
A.N. Khabibrakhmanov, M.A. Mukhamedyarov & E.I. Bogdanov. (2022) Biomarkers of amyotrophic lateral sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:5, pages 30.
Crossref
Magisetty Obulesu. 2022. Plant Extracts in Neurodegenerative Diseases. Plant Extracts in Neurodegenerative Diseases 117 129 .
S. Asha Devi & T. B. Basavaraju. 2022. Redox Signaling and Biomarkers in Ageing. Redox Signaling and Biomarkers in Ageing 45 64 .
Cory J. Holdom, Frederik J. Steyn, Robert D. Henderson, Pamela A. McCombe, Mary-Louise Rogers & Shyuan T. Ngo. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers 263 306 .
Bridget C. Benson, Pamela J. Shaw, Mimoun Azzouz, J. Robin Highley & Guillaume M. Hautbergue. (2021) Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 15.
Crossref
Dong-Hoon Hyun & Jaewang Lee. (2021) A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases. Antioxidants 11:1, pages 7.
Crossref
Federica Ghelli, Valeria Bellisario, Giulia Squillacioti, Elena Grignani, Giacomo Garzaro, Martina Buglisi, Enrico Bergamaschi & Roberto Bono. (2021) Oxidative stress induction in woodworkers occupationally exposed to wood dust and formaldehyde. Journal of Occupational Medicine and Toxicology 16:1.
Crossref
Jan Stein, Bernd Walkenfort, Hilal Cihankaya, Mike Hasenberg, Verian Bader, Konstanze F. Winklhofer, Pascal Röderer, Johann Matschke, Carsten Theiss & Veronika Matschke. (2021) Increased ROS-Dependent Fission of Mitochondria Causes Abnormal Morphology of the Cell Powerhouses in a Murine Model of Amyotrophic Lateral Sclerosis. Oxidative Medicine and Cellular Longevity 2021, pages 1-16.
Crossref
Takashi Hosaka, Hiroshi Tsuji & Akira Tamaoka. (2021) Biomolecular Modifications Linked to Oxidative Stress in Amyotrophic Lateral Sclerosis: Determining Promising Biomarkers Related to Oxidative Stress. Processes 9:9, pages 1667.
Crossref
Valentina Novak, Boris Rogelj & Vera Župunski. (2021) Therapeutic Potential of Polyphenols in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Antioxidants 10:8, pages 1328.
Crossref
James BerryBenjamin Brooks, Angela GengeTerry Heiman-PattersonStanley AppelMichael BenatarRobert BowserMerit CudkowiczClifton GoochJeremy ShefnerJurjen WestraWendy AgneseCharlotte MerrillSally NelsonStephen Apple. (2021) Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS). Neurology Clinical Practice 11:4.
Crossref
Jannigje Rachel Kok, Nelma M. Palminha, Cleide Dos Santos Souza, Sherif F. El-Khamisy & Laura Ferraiuolo. (2021) DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity. Cellular and Molecular Life Sciences 78:15, pages 5707-5729.
Crossref
Kiyoung Kim. (2021) Glutathione in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis. Antioxidants 10:7, pages 1011.
Crossref
Liuji Chen, Ren Na, Kirsten Danae McLane, Cody Sylvester Thompson, Ju Gao, Xinglong Wang & Qitao Ran. (2021) Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Scientific Reports 11:1.
Crossref
Cyril Quessada, Alexandra Bouscary, Frédérique René, Cristiana Valle, Alberto Ferri, Shyuan T. Ngo & Jean-Philippe Loeffler. (2021) Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?. Cells 10:6, pages 1449.
Crossref
Matan Soll, Hagit Goldshtein, Ron Rotkopf, Niva Russek-Blum & Zeev Gross. (2021) A Synthetic SOD/Catalase Mimic Compound for the Treatment of ALS. Antioxidants 10:6, pages 827.
Crossref
Aksu Gunay, Heather H. Shin, Oge Gozutok, Mukesh Gautam & P. Hande Ozdinler. (2021) Importance of lipids for upper motor neuron health and disease. Seminars in Cell & Developmental Biology 112, pages 92-104.
Crossref
T.J. Tracey, S.E. Kirk, F.J. Steyn & S.T. Ngo. (2021) The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Seminars in Cell & Developmental Biology 112, pages 69-81.
Crossref
Bhaskar Roy & Robert Griggs. (2021) Advances in Treatments in Muscular Dystrophies and Motor Neuron Disorders. Neurologic Clinics 39:1, pages 87-112.
Crossref
Teresa Cunha-Oliveira, Liliana Montezinho, Catarina Mendes, Omidreza Firuzi, Luciano Saso, Paulo J. Oliveira & Filomena S. G. Silva. (2020) Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity 2020, pages 1-29.
Crossref
Snjezana Petrovic, Aleksandra Arsic, Danijela Ristic-Medic, Zorica Cvetkovic & Vesna Vucic. (2020) Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies. Antioxidants 9:11, pages 1128.
Crossref
Masamichi Ikawa, Hidehiko Okazawa, Yasunari Nakamoto & Makoto Yoneda. (2020) PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction. Antioxidants 9:9, pages 861.
Crossref
Mattéa J. Finelli. (2020) Redox Post-translational Modifications of Protein Thiols in Brain Aging and Neurodegenerative Conditions—Focus on S-Nitrosation. Frontiers in Aging Neuroscience 12.
Crossref
Serpil Ersan, Burhanettin Cigdem, Deniz Bakir & H. Okan Dogan. (2020) Determination of levels of oxidative stress and nitrosative stress in patients with epilepsy. Epilepsy Research 164, pages 106352.
Crossref
Lilia A. Koza, Aimee N. Winter, Jessica Holsopple, Angela N. Baybayon-Grandgeorge, Claudia Pena, Jeffrey R. Olson, Randall C. Mazzarino, David Patterson & Daniel A. Linseman. (2020) Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Nutrients 12:6, pages 1824.
Crossref
Cristina Ruiz-Ruiz, Francesco Calzaferri & Antonio G. García. (2020) P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 13.
Crossref
Haley Yost, Riya Patel, Anders Kipp & Tanea T. Reed. 2005. Bailey's Industrial Oil and Fat Products. Bailey's Industrial Oil and Fat Products 1 29 .
Sandra Carrera-Juliá, Mari Luz Moreno, Carlos Barrios, Jose Enrique de la Rubia Ortí & Eraci Drehmer. (2020) Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Frontiers in Physiology 11.
Crossref
Yue-Qing Yang, Yong-Hui Zheng, Chun-Ting Zhang, Wei-Wei Liang, Shu-Yu Wang, Xu-Dong Wang, Ying Wang, Tian-Hang Wang, Hong-Quan Jiang & Hong-Lin Feng. (2020) Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis. Neurobiology of Disease 134, pages 104648.
Crossref
Christine Germeys, Tijs Vandoorne, Valérie Bercier & Ludo Van Den Bosch. (2019) Existing and Emerging Metabolomic Tools for ALS Research. Genes 10:12, pages 1011.
Crossref
Emma F. Smith, Pamela J. Shaw & Kurt J. De Vos. (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neuroscience Letters 710, pages 132933.
Crossref
Tesfaye Wolde Tefera, Katherine Bartlett, Shirley S. Tran, Mark P. Hodson & Karin Borges. (2019) Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Molecular Neurobiology 56:8, pages 5844-5855.
Crossref
Fabrice Collin. (2019) Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases. International Journal of Molecular Sciences 20:10, pages 2407.
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Tiyasha Sarkar, Nisha Patro & Ishan K. Patro. (2019) Cumulative multiple early life hits- a potent threat leading to neurological disorders. Brain Research Bulletin 147, pages 58-68.
Crossref
David Devos, Caroline Moreau, Maeva Kyheng, Guillaume Garçon, Anne Sophie Rolland, Hélène Blasco, Patrick Gelé, T. Timothée Lenglet, C. Veyrat-Durebex, Philippe Corcia, Mary Dutheil, Peter Bede, Andreas Jeromin, Patrick Oeckl, Markus Otto, Vincent Meininger, Véronique Danel-Brunaud, Jean-christophe Devedjian, James A. Duce & Pierre François Pradat. (2019) A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Scientific Reports 9:1.
Crossref
Xu-Dong Wang, Min-Wei Zhu, Dan Shan, Shu-Yu Wang, Xiang Yin, Yue-Qing Yang, Tian-Hang Wang, Chun-Ting Zhang, Ying Wang, Wei-Wei Liang, Jun Zhang, Hai-Zhi Jiang, Guang-Tao Dong, Hong-Quan Jiang, Yan Qi & Hong-Lin Feng. (2019) Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage. DNA Repair 74, pages 51-62.
Crossref
Linting Luo, Zhibin Song, Xiaoqiang Li, Huiwang, Yaqing Zeng, Qinwang, Meiqi & Jianli He. (2018) Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis—a systematic review and meta-analysis. Neurological Sciences 40:2, pages 235-241.
Crossref
Jeffrey M. Statland, Dan Moore, Yunxia Wang, Maureen Walsh, Tahseen Mozaffar, Lauren Elman, Sharon P. Nations, Hiroshi Mitsumoto, J. Americo Fernandes, David Saperstein, Ghazala Hayat, Laura Herbelin, Chafic Karam, Jonathan Katz, Heather M. Wilkins, Abdulbaki Agbas, Russell H. Swerdlow, Regina M. Santella, Mazen M. Dimachkie & Richard J. Barohn. (2018) Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Muscle & Nerve 59:2, pages 201-207.
Crossref
J. Riancho, I. Gonzalo, M. Ruiz-Soto & J. Berciano. (2019) Why do motor neurons degenerate? Actualisation in the pathogenesis of amyotrophic lateral sclerosis. Neurología (English Edition) 34:1, pages 27-37.
Crossref
J. Riancho, I. Gonzalo, M. Ruiz-Soto & J. Berciano. (2019) ¿Por qué degeneran las motoneuronas? Actualización en la patogenia de la esclerosis lateral amiotrófica. Neurología 34:1, pages 27-37.
Crossref
Rup Tandan, Waqar Waheed & Connor Scagnelli. 2019. Handbook of Famine, Starvation, and Nutrient Deprivation. Handbook of Famine, Starvation, and Nutrient Deprivation 981 1033 .
Rup Tandan, Waqar Waheed & Connor Scagnelli. 2019. Handbook of Famine, Starvation, and Nutrient Deprivation. Handbook of Famine, Starvation, and Nutrient Deprivation 1 53 .
Kuo-Hsuan Chang, Mei-Ling Cheng, Mu-Chun Chiang & Chiung-Mei Chen. (2018) Lipophilic antioxidants in neurodegenerative diseases. Clinica Chimica Acta 485, pages 79-87.
Crossref
Abhishek Vats, Mandaville Gourie-Devi, Kavita Ahuja, Ankkita Sharma, Saima Wajid, Nirmal Kumar Ganguly & Vibha Taneja. (2018) Expression analysis of protein homeostasis pathways in the peripheral blood mononuclear cells of sporadic amyotrophic lateral sclerosis patients. Journal of the Neurological Sciences 387, pages 85-91.
Crossref
Timothy J. Tracey, Frederik J. Steyn, Ernst J. Wolvetang & Shyuan T. Ngo. (2018) Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease. Frontiers in Molecular Neuroscience 11.
Crossref
Hiroshi MitsumotoToyokazu Saito. (2018) A prognostic biomarker in amyotrophic lateral sclerosis筋萎縮性側索硬化症の進行を示すバイオマーカー. Rinsho Shinkeigaku 58:12, pages 729-736.
Crossref
Thomas J. van 't Erve, Maria B. Kadiiska, Stephanie J. London & Ronald P. Mason. (2017) Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis. Redox Biology 12, pages 582-599.
Crossref
Koji Abe, Masashi Aoki, Shoji Tsuji, Yasuto Itoyama, Gen Sobue, Masanori Togo, Chikuma Hamada, Masahiko Tanaka, Makoto Akimoto, Kazue Nakamura, Fumihiro Takahashi, Kazuoki Kondo, Hiide Yoshino, Koji Abe, Masashi Aoki, Shoji Tsuji, Yasuto Itoyama, Gen Sobue, Masanori Togo, Chikuma Hamada, Hidenao Sasaki, Ichiro Yabe, Shizuki Doi, Hitoshi Warita, Takashi Imai, Hiroaki Ito, Mitsumasa Fukuchi, Etsuko Osumi, Manabu Wada, Imaharu Nakano, Mitsuya Morita, Katsuhisa Ogata, Yuichi Maruki, Kimiko Ito, Osamu Kano, Mineo Yamazaki, Yuji Takahashi, Hiroyuki Ishiura, Mieko Ogino, Ryoko Koike, Chiho Ishida, Tsuyoshi Uchiyama, Kouichi Mizoguchi, Tomokazu Obi, Hirohisa Watanabe, Naoki Atsuta, Ikuko Aiba, Akira Taniguchi, Hideyuki Sawada, Takanori Hazama, Harutoshi Fujimura, Hirofumi Kusaka, Takenobu Kunieda, Hitoshi Kikuchi, Hidenori Matsuo, Hidetsugu Ueyama, Kazutoshi Uekawa, Masahiko Tanaka, Makoto Akimoto, Masaki Ueda, Aiko Murakami, Rie Sumii, Takuya Kudou, Kazue Nakamura, Kazunori Morimoto, Takatomo Yoneoka, Manabu Hirai, Kouichi Sasaki, Hidetomo Terai, Tomoko Natori, Hiroshi Matsui, Kuniko Kotani, Kaori Yoshida, Tomohisa Iwasaki, Fumihiro Takahashi, Kazuoki Kondo & Hiide Yoshino. (2017) Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. The Lancet Neurology 16:7, pages 505-512.
Crossref
Tanea T. Reed & D. Allan Butterfield. 2017. Protein Carbonylation. Protein Carbonylation 167 205 .
B R Cardoso, D J Hare, A I Bush & B R Roberts. (2016) Glutathione peroxidase 4: a new player in neurodegeneration?. Molecular Psychiatry 22:3, pages 328-335.
Crossref
Stefanie M. A. Willekens, Donatienne Van Weehaeghe, Philip Van Damme & Koen Van Laere. (2016) Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks. European Journal of Nuclear Medicine and Molecular Imaging 44:3, pages 533-547.
Crossref
Sammy Zahran, Mark A.S. Laidlaw, Dominic B. Rowe, Andrew S. Ball & Howard W. Mielke. (2017) Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia. Environmental Research 153, pages 181-190.
Crossref
Hélène Blasco, Guillaume Garcon, Franck Patin, Charlotte Veyrat-Durebex, Judith Boyer, David Devos, Patrick Vourc’h, Christian R. Andres & Philippe Corcia. (2016) Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 44:1, pages 90-95.
Crossref
Lucas T. Vu & Robert Bowser. (2016) Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 119-134.
Crossref
Renzo Mancuso & Xavier Navarro. 2017. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Sigma Receptors: Their Role in Disease and as Therapeutic Targets 235 254 .
Ewa Niedzielska, Irena Smaga, Maciej Gawlik, Andrzej Moniczewski, Piotr Stankowicz, Joanna Pera & Małgorzata Filip. (2015) Oxidative Stress in Neurodegenerative Diseases. Molecular Neurobiology 53:6, pages 4094-4125.
Crossref
Teresa M. Evans, Arunabh Bhattacharya, Yun Shi, Wenbo Qi, Travis J. Block, Asish Chaudhuri, Alakananda Ray Chaudhuri, Kara Hawker & Holly Van Remmen. (2016) Moderate modulation of disease in the G93A model of ALS by the compound 2-(2-hydroxyphenyl)-benzoxazole (HBX). Neuroscience Letters 624, pages 1-7.
Crossref
Pavel RossnerJr.Jr., Hilmi Orhan, Gudrun Koppen, Kazuo Sakai, Regina M. Santella, Antonin Ambroz, Andrea Rossnerova, Radim J. Sram, Miroslav Ciganek, Jiri Neca, Ege Arzuk, Neliye Mutlu & Marcus S. Cooke. (2016) Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine analysis by an improved ELISA: An inter-laboratory comparison study. Free Radical Biology and Medicine 95, pages 169-179.
Crossref
Michela Dell'Orco, Pamela Milani, Laura Arrigoni, Orietta Pansarasa, Valentina Sardone, Elisa Maffioli, Francesca Polveraccio, Matteo Bordoni, Luca Diamanti, Mauro Ceroni, Fiorenzo A. Peverali, Gabriellla Tedeschi & Cristina Cereda. (2016) Hydrogen peroxide-mediated induction of SOD1 gene transcription is independent from Nrf2 in a cellular model of neurodegeneration. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1859:2, pages 315-323.
Crossref
Sergio Di Meo, Tanea T. Reed, Paola Venditti & Victor Manuel Victor. (2016) Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxidative Medicine and Cellular Longevity 2016, pages 1-44.
Crossref
Valeria Bellisario, Giulio Mengozzi, Elena Grignani, Massimiliano Bugiani, Anna Sapino, Gianni Bussolati & Roberto Bono. (2016) Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres. Toxicology Research 5:4, pages 1122-1129.
Crossref
Mark Laidlaw, Dominic Rowe, Andrew Ball & Howard Mielke. (2015) A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia. International Journal of Environmental Research and Public Health 12:12, pages 16124-16135.
Crossref
Jared Ehrhart, Adam J. Smith, Nicole Kuzmin-Nichols, Theresa A. Zesiewicz, Israt Jahan, R. Douglas Shytle, Seol-Hee Kim, Cyndy D. Sanberg, Tuan H. Vu, Clifton L. Gooch, Paul R. Sanberg & Svitlana Garbuzova-Davis. (2015) Humoral factors in ALS patients during disease progression. Journal of Neuroinflammation 12:1.
Crossref
Renzo Mancuso & Xavier Navarro. (2015) Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic. Progress in Neurobiology 133, pages 1-26.
Crossref
Masamichi IkawaHidehiko OkazawaTetsuya TsujikawaAkiko MatsunagaOsamu YamamuraTetsuya MoriTadanori HamanoYasushi KiyonoYasunari NakamotoMakoto Yoneda. (2015) Increased oxidative stress is related to disease severity in the ALS motor cortex. Neurology 84:20, pages 2033-2039.
Crossref
Makito Hirano, Yusaku Nakamura, Kazumasa Saigoh, Hikaru Sakamoto, Shuichi Ueno, Chiharu Isono, Yoshiyuki Mitsui & Susumu Kusunoki. (2015) VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation. Neurobiology of Aging 36:3, pages 1604.e1-1604.e6.
Crossref
Morenci M. Manning & Marie Kelly-Worden. (2015) Potential Regulators of Sporadic ALS Development and Alternative Therapeutic Options. Neuroscience and Medicine 06:01, pages 5-12.
Crossref
Eva de Lago, Miguel Moreno-Martet, Francisco Espejo-Porras & Javier Fernández-Ruiz. 2015. Cannabinoids in Neurologic and Mental Disease. Cannabinoids in Neurologic and Mental Disease 99 123 .
Khanh vinh quốc Lương & Lan Thi Hoàng Nguyễn. 2015. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease 261 279 .
Hongquan Jiang, Changsong Wang, Ming Ren, Xiang Yin, Chunjie Chi, Lei Guo, Chaofu Ke, Honglin Feng & Enyou Li. (2014) Blood Volatile Organic Compounds as Potential Biomarkers for Amyotrophic Lateral Sclerosis: an Animal Study in the SOD1 G93A Mouse. Journal of Molecular Neuroscience 55:1, pages 167-173.
Crossref
Steve Vucic, Jeffrey D. Rothstein & Matthew C. Kiernan. (2014) Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies. Trends in Neurosciences 37:8, pages 433-442.
Crossref
Cheppail Ramachandran, Karl-Werner Quirin, Enrique Escalon & Steven J. Melnick. (2014) Improved Neuroprotective Effects by Combining Bacopa monnieri and Rosmarinus officinalis Supercritical CO 2 Extracts . Journal of Evidence-Based Complementary & Alternative Medicine 19:2, pages 119-127.
Crossref
M. Hadzhieva, E. Kirches & C. Mawrin. (2014) Review: Iron metabolism and the role of iron in neurodegenerative disorders. Neuropathology and Applied Neurobiology 40:3, pages 240-257.
Crossref
Laura FerraiuoloKathrin Meyer. (2014) Astrocyte toxicity in motor neuron disease: progress and future hopes. Future Neurology 9:2, pages 149-161.
Crossref
Elżbieta Miller, Agnieszka Morel, Luciano Saso & Joanna Saluk. (2014) Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2014, pages 1-10.
Crossref
Mototada Shichiri, Yasukazu Yoshida & Etsuo Niki. 2014. Omega-3 Fatty Acids in Brain and Neurological Health. Omega-3 Fatty Acids in Brain and Neurological Health 31 55 .
Roisin Lonergan, Hiroshi Mistumoto & Brian Murray. 2014. Neuromuscular Disorders in Clinical Practice. Neuromuscular Disorders in Clinical Practice 395 423 .
Emanuele D’Amico, Pam Factor-Litvak, Regina M. Santella & Hiroshi Mitsumoto. (2013) Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radical Biology and Medicine 65, pages 509-527.
Crossref
Boya Song, Shenmin Pan, Chi Tang, Dandan Li & James F. Rusling. (2013) Voltammetric Microwell Array for Oxidized Guanosine in Intact ds-DNA. Analytical Chemistry 85:22, pages 11061-11067.
Crossref
Hélène Blasco, Philippe CorciaPaul H Gordon & Pierre-François Pradat. (2013) Biological and neuroimaging biomarkers for amyotrophic lateral sclerosis: 2013 and beyond. Neurodegenerative Disease Management 3:5, pages 427-444.
Crossref
Rachele A. Saccon, Rosie K. A. Bunton-Stasyshyn, Elizabeth M.C. Fisher & Pietro Fratta. (2013) Is SOD1 loss of function involved in amyotrophic lateral sclerosis?. Brain 136:8, pages 2342-2358.
Crossref
Rukhsana Sultana, Giovanna Cenini & D. Allan Butterfield. 2013. Molecular Basis of Oxidative Stress. Molecular Basis of Oxidative Stress 359 376 .
Jakob Maximilian Moser, Paolo Bigini & Thomas Schmitt-John. (2013) The wobbler mouse, an ALS animal model. Molecular Genetics and Genomics 288:5-6, pages 207-229.
Crossref
Khanh vinh quốc Lương & Lan Thi Hoàng Nguyễn. (2013) Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms. Molecular Brain 6:1, pages 16.
Crossref
Valeria Romanazzi, Valentina Pirro, Valeria Bellisario, Giulio Mengozzi, Marco Peluso, Marco Pazzi, Massimiliano Bugiani, Giuseppe Verlato & Roberto Bono. (2013) 15-F2t isoprostane as biomarker of oxidative stress induced by tobacco smoke and occupational exposure to formaldehyde in workers of plastic laminates. Science of The Total Environment 442, pages 20-25.
Crossref
Tomoo Mano, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Noriaki Suga, Atsushi Hashizume, Fumiaki Tanaka & Gen Sobue. (2012) Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy. Muscle & Nerve 46:5, pages 692-697.
Crossref
Vikram Khipple Mulligan, Aaron Kerman, Rob C. Laister, Priya Roy Sharda, Pharhad Eli Arslan & Avijit Chakrabartty. (2012) Early Steps in Oxidation-Induced SOD1 Misfolding: Implications for Non-Amyloid Protein Aggregation in Familial ALS. Journal of Molecular Biology 421:4-5, pages 631-652.
Crossref
Silvia Sorce, Karl-Heinz Krause & Vincent Jaquet. (2012) Targeting NOX enzymes in the central nervous system: therapeutic opportunities. Cellular and Molecular Life Sciences 69:14, pages 2387-2407.
Crossref
Richard S. Finkel, Thomas O. Crawford, Kathryn J. Swoboda, Petra Kaufmann, Peter Juhasz, Xiaohong Li, Yu Guo, Rebecca H. Li, Felicia Trachtenberg, Suzanne J. Forrest, Dione T. Kobayashi, Karen S. Chen, Cynthia L. Joyce & Thomas Plasterer. (2012) Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study. PLoS ONE 7:4, pages e35462.
Crossref
Ana C. Calvo, Raquel Manzano, Gabriela Atencia-Cibreiro, Sara Oliván, María J. Muñoz, Pilar Zaragoza, Pilar Cordero-Vázquez, Jesús Esteban-Pérez, Alberto García-Redondo & Rosario Osta. (2012) Genetic Biomarkers for ALS Disease in Transgenic SOD1G93A Mice. PLoS ONE 7:3, pages e32632.
Crossref
Laura Ferraiuolo, Janine Kirby, Andrew J. Grierson, Michael Sendtner & Pamela J. Shaw. (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nature Reviews Neurology 7:11, pages 616-630.
Crossref
Natalie A. Kelsey, Heather M. Wilkins & Daniel A. Linseman. (2010) Nutraceutical Antioxidants as Novel Neuroprotective Agents. Molecules 15:11, pages 7792-7814.
Crossref
Malcolm Ward & Emma Louise Schofield. (2010) Biomarkers for brain disorders. Therapy 7:4, pages 321-336.
Crossref
Jeban Ganesalingam & Robert Bowser. (2010) The application of biomarkers in clinical trials for motor neuron disease. Biomarkers in Medicine 4:2, pages 281-297.
Crossref
Robert Bowser & David Lacomis. (2009) Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle & Nerve 40:5, pages 753-762.
Crossref
Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen‐Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven P. Novella, Terry Heiman‐Patterson, Edward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra Barsdorf, Hiroshi Mitsumoto & Bruce Levin. (2009) Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Annals of Neurology 66:2, pages 235-244.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.